Recently, studies from Li et al. discovered that high CBX1 expression was connected to aggressive types of breast cancers (TNBC phenotype), and the patients were inclined to have P53 mutations and lymph node metastasis (Li X et al., 2020). This evidence concerns the gene CBX1 and breast carcinoma.